Company: LICN
Filing Date: 2025-01-29
Form Type: 424B5
Source: 0001213900-25-007741
Chunk: 82

Company: Lichen International Ltd
Filing Date: 2025-01-29
Form: 424B5
Chunk 82
---
 during the fiscal year ended December 31, 2021. As
of the date of this prospectus, except for the previously mentioned dividend payments in fiscal year 2020, neither the Company nor its
subsidiaries have made other transfers, dividends, or distributions to investors and no investors have made transfers, dividends, or distributions
to the Company or its subsidiaries. As of the date of this prospectus, no dividends, distributions or transfers has been made between
Lichen China Limited and any of its subsidiaries. We do not expect to pay any cash dividends in the foreseeable future. Also, as of the
date of this prospectus, no cash generated from one subsidiary is used to fund another subsidiary’s operations and we do not anticipate
any difficulties or limitations on our ability to transfer cash between subsidiaries. See “Prospectus Summary — Transfers
of Cash to and from Our Subsidiaries” on page 7 and “Consolidated Financial Statements” incorporated by reference
into this prospectus.

We are an “emerging growth company” as defined under federal securities laws and, as such, will be subject to reduced public company reporting requirements. See “Prospectus Summary — Implications of Being an Emerging Growth Company” and “Prospectus Summary — Implications of Being a Foreign Private Issuer” on page 5 for additional information.

This prospectus may not be used to offer or sell our securities unless accompanied by a prospectus supplement. The information contained or incorporated in this prospectus or in any prospectus supplement is accurate only as of the date of this prospectus, or such prospectus supplement, as applicable, regardless of the time of delivery of this prospectus or any sale of our securities.

Investing in our securities being offered pursuant to this prospectus involves a high degree of risk. You should carefully read and consider the ‘‘Risk Factors’’ section of this prospectus, and risk factors set forth in our most recent annual report on Form 20-F, in other reports incorporated herein by reference,and in the applicable prospectus supplement before you make your investment decision.

Neither the Securities and Exchange Commission, the Cayman Islands Monetary Authority, nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is , 2024

TABLE OF CONTENTS</div>

|                                                                  |     | Page |
| ABOUT THIS PROS